Trial Profile
A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Nafithromycin (Primary)
- Indications Community-acquired pneumonia
- Focus Pharmacokinetics
- Sponsors Wockhardt
- 31 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 01 Jun 2015 New trial record